AGP Executive Report
Last update: an hour agoNew Treatment: The FDA approved pritelivir for hard-to-treat herpes infections in immunocompromised adults. In a trial, 63% of patients had healed lesions by day 28, compared with 34% on other treatments. Clinical Trial Equity: Louisville leaders called for more Black participation in lung cancer trials, addressing a gap in a state with the nation’s highest lung cancer rate. Medicare Choices: Open enrollment has begun as insurers drop some Medicare Advantage plans, leaving many seniors to weigh fewer options and higher costs. Drug Safety: UK regulators plan stronger antidepressant warnings on suicidal thoughts and persistent sexual side effects; a separate raid seized more than 12,000 counterfeit weight-loss pens. Rare Disease Policy: The FDA is developing a disease-specific framework for reviewing rare-disease medicines, with public feedback due at an October 28 meeting.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
